ScoreWhy is Double Medical Technology, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 9.52% and Operating profit at -2.29% over the last 5 years
2
The company has declared Positive results for the last 9 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 879.91 MM
- NET SALES(9M) At CNY 2,031.92 MM has Grown at 18.01%
- ROCE(HY) Highest at 18.59%
3
With ROE of 17.21%, it has a fair valuation with a 3.78 Price to Book Value
- Over the past year, while the stock has generated a return of 26.17%, its profits have risen by 50.9% ; the PEG ratio of the company is 0.4
- At the current price, the company has a high dividend yield of 0
4
Market Beating performance in long term as well as near term
- Along with generating 26.17% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Double Medical Technology, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Double Medical Technology, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Double Medical Technology, Inc.
-22.39%
1.59
39.36%
China Shanghai Composite
8.25%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.52%
EBIT Growth (5y)
-2.29%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.58
Tax Ratio
12.72%
Dividend Payout Ratio
40.70%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.08%
ROE (avg)
13.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
4.65
EV to EBIT
25.35
EV to EBITDA
19.68
EV to Capital Employed
6.99
EV to Sales
5.90
PEG Ratio
0.53
Dividend Yield
NA
ROCE (Latest)
27.58%
ROE (Latest)
17.21%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 879.91 MM
NET SALES(9M)
At CNY 2,031.92 MM has Grown at 18.01%
ROCE(HY)
Highest at 18.59%
INVENTORY TURNOVER RATIO(HY)
Highest at 0.63 times
DEBTORS TURNOVER RATIO(HY)
Highest at 8.59 times
RAW MATERIAL COST(Y)
Fallen by -9.23% (YoY
NET PROFIT(9M)
Higher at CNY 461.57 MM
CASH AND EQV(HY)
Highest at CNY 3,559.17 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -38.93 %
-2What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.49 times
OPERATING PROFIT MARGIN(Q)
Lowest at 26.18 %
Here's what is working for Double Medical Technology, Inc.
Operating Cash Flow
Highest at CNY 879.91 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Inventory Turnover Ratio
Highest at 0.63 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 8.59 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Sales
At CNY 2,031.92 MM has Grown at 18.01%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Net Profit
At CNY 461.57 MM has Grown at 47.77%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Cash and Eqv
Highest at CNY 3,559.17 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -38.93 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Profit
Higher at CNY 461.57 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Profit (CNY MM)
Raw Material Cost
Fallen by -9.23% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Double Medical Technology, Inc.
Operating Profit Margin
Lowest at 26.18 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Inventory Turnover Ratio
Lowest at 0.49 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
